In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp.

The in vitro activities of ravuconazole and voriconazole were compared with those of amphotericin B, flucytosine (5FC), itraconazole, and fluconazole against 6,970 isolates of Candida spp. obtained from over 200 medical centers worldwide. Both ravuconazole and voriconazole were very active against a...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Pfaller, M. A., Messer, S. A., Hollis, R. J., Jones, R. N., Diekema, D. J.
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2002
Sujets:	Susceptibility
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127275/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12019081/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.6.1723-1727.2002
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!